Remote Speech and Swallowing Assessment in ALS
NCT: NCT04889898 · COMPLETED
Brief Summary
The investigators propose a longitudinal home study of ALS patients to measure the severity of speech and swallowing (bulbar) impairment via a smartphone-based, remote speech and swallow assessment (rSSA). The study is designed to assess the feasibility and validity of such a monitoring intervention. Furthermore, it is proposed that regular monitoring of these two bulbar processes may shed light on their co-evolution over the course of ALS.
Frequently Asked Questions
What is Remote Speech and Swallowing Assessment in ALS?
Remote Speech and Swallowing Assessment in ALS is a clinical trial registered under NCT04889898. Current status: COMPLETED.
What is the status of NCT04889898?
The current status of NCT04889898 (Remote Speech and Swallowing Assessment in ALS) is: COMPLETED.
When did Remote Speech and Swallowing Assessment in ALS start?
Remote Speech and Swallowing Assessment in ALS started on 2022-01-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.